1. Home
  2. IFS vs KYMR Comparison

IFS vs KYMR Comparison

Compare IFS & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IFS
  • KYMR
  • Stock Information
  • Founded
  • IFS 1897
  • KYMR 2015
  • Country
  • IFS Peru
  • KYMR United States
  • Employees
  • IFS N/A
  • KYMR N/A
  • Industry
  • IFS Commercial Banks
  • KYMR Medicinal Chemicals and Botanical Products
  • Sector
  • IFS Finance
  • KYMR Health Care
  • Exchange
  • IFS Nasdaq
  • KYMR Nasdaq
  • Market Cap
  • IFS 3.3B
  • KYMR 3.0B
  • IPO Year
  • IFS 2019
  • KYMR 2020
  • Fundamental
  • Price
  • IFS $29.15
  • KYMR $42.30
  • Analyst Decision
  • IFS Buy
  • KYMR Buy
  • Analyst Count
  • IFS 1
  • KYMR 16
  • Target Price
  • IFS $30.00
  • KYMR $54.00
  • AVG Volume (30 Days)
  • IFS 167.9K
  • KYMR 456.9K
  • Earning Date
  • IFS 02-10-2025
  • KYMR 10-31-2024
  • Dividend Yield
  • IFS 3.42%
  • KYMR N/A
  • EPS Growth
  • IFS N/A
  • KYMR N/A
  • EPS
  • IFS 2.58
  • KYMR N/A
  • Revenue
  • IFS $1,107,663,227.00
  • KYMR $87,563,000.00
  • Revenue This Year
  • IFS N/A
  • KYMR N/A
  • Revenue Next Year
  • IFS $9.51
  • KYMR $33.16
  • P/E Ratio
  • IFS $11.33
  • KYMR N/A
  • Revenue Growth
  • IFS N/A
  • KYMR 86.92
  • 52 Week Low
  • IFS $20.14
  • KYMR $22.35
  • 52 Week High
  • IFS $30.59
  • KYMR $53.27
  • Technical
  • Relative Strength Index (RSI)
  • IFS 59.44
  • KYMR 41.34
  • Support Level
  • IFS $28.79
  • KYMR $40.95
  • Resistance Level
  • IFS $29.68
  • KYMR $44.17
  • Average True Range (ATR)
  • IFS 0.62
  • KYMR 2.32
  • MACD
  • IFS 0.01
  • KYMR -0.33
  • Stochastic Oscillator
  • IFS 66.37
  • KYMR 16.07

About IFS Intercorp Financial Services Inc.

Intercorp Financial Services Inc is a provider of financial services through banking, insurance, and wealth management businesses, as well as the recent integration of Izipay enhancing its payments ecosystem. The company has four operating segments; the Banking segment includes Mainly loans, credit facilities, deposits, and current accounts, the Insurance segment provides life annuity products with single-premium payment and conventional life insurance products and other retail insurance products, the Wealth Management segment provides brokerage and investment management services, and Payments segment provides administration services, operation and processing of credit and debit cards. Its geographical segments include Peru and Panama.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.

Share on Social Networks: